Radiologic diagnosis of bone metastases

Metastatic cancer often involves the skeleton. Tumor most often reaches the bones by hematogenous spread; however, direct extension from the primary tumor or from another site of metastasis, as well as lymphatic dissemination, may occur. Clinical features depend on the affected sites and the extent of disease. The radioisotope bone scan has been the preferred imaging screening modality. Magnetic resonance imaging is probably more sensitive in the detection of axial lesions, but additional development is needed before it can replace the isotope scan in evaluation of the long bones. For patients presenting with metastatic disease, the appearance of the lesions may help to guide the search for a primary. Some helpful patterns include lytic and sclerotic lesions, "expanded" lesions, "pseudosarcomatous" lesions, acral lesions, and soft tissue ossification. Evaluation of response to therapy is problematic. Progressive sclerosis of a lytic focus generally indicates a positive response. Pitfalls in the evaluation of response include the "flare" phenomenon, which has been observed on radioisotope scans early in the course of therapy. Cancer 1997; 80:1595‐607. © 1997 American Cancer Society.

[1]  M. Reiser,et al.  Contrast enhancement and quantitative signal analysis in MR imaging of multiple myeloma: assessment of focal and diffuse growth patterns in marrow correlated with biopsies and survival rates. , 1996, AJR. American journal of roentgenology.

[2]  A. Gangi,et al.  Injection of Alcohol into Bone Metastases under CT Guidance , 1994, Journal of computer assisted tomography.

[3]  J. Moore,et al.  Bone Metastasis , 1982, British Journal of Cancer.

[4]  P. Peters,et al.  Response of osteosarcoma and Ewing sarcoma to preoperative chemotherapy: assessment with dynamic and static MR imaging and skeletal scintigraphy. , 1990, Radiology.

[5]  P. Woll,et al.  Treatment of bone metastases from breast cancer with (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD). , 1988, British Journal of Cancer.

[6]  D. Rosenthal,et al.  Percutaneous biopsy of skeletal lesions. , 1991, AJR. American journal of roentgenology.

[7]  S. Kosuda,et al.  Does bone SPECT actually have lower sensitivity for detecting vertebral metastasis than MRI? , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[8]  P. Babin,et al.  Strategy for identifying primary malignancies with inaugural bone metastases. , 1995, Revue du rhumatisme.

[9]  K. Sugimura,et al.  Assessing response to therapy of spinal metastases with gadolinium‐enhanced MR imaging , 1991, Journal of magnetic resonance imaging : JMRI.

[10]  D. Renfrew,et al.  Percutaneous needle biopsy of musculoskeletal lesions. 2. Cost-effectiveness. , 1992, AJR. American journal of roentgenology.

[11]  M. Fisher Lumbar spine metastasis in cervical carcinoma: a characteristic pattern. , 1980, Radiology.

[12]  P. Colletti,et al.  Spinal MR imaging in suspected metastases: correlation with skeletal scintigraphy. , 1991, Magnetic resonance imaging.

[13]  M. Simon,et al.  Skeletal metastases of unknown origin. A prospective study of a diagnostic strategy. , 1993, The Journal of bone and joint surgery. American volume.

[14]  G. Hortobagyi,et al.  Efficacy of pamidronate in reducing skeletal complications in patients with breast cancer and lytic bone metastases. Protocol 19 Aredia Breast Cancer Study Group. , 1996, The New England journal of medicine.

[15]  Bone marrow immunoscintigraphy versus conventional bone scintigraphy in the diagnosis of skeletal metastases in urogenital malignancies. , 1994, European urology.

[16]  I. Fogelman,et al.  The bone scan: where are we now? , 1995, Seminars in nuclear medicine.

[17]  A. Elias,et al.  Gallium imaging in metastatic and recurrent soft-tissue sarcoma. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[18]  D. Resnick Diagnosis of Bone and Joint Disorders , 1987 .

[19]  R. Wahl,et al.  Metastatic prostate cancer: initial findings of PET with 2-deoxy-2-[F-18]fluoro-D-glucose. , 1996, Radiology.

[20]  M. J. Fusselman,et al.  Benign versus malignant intraosseous lesions: discrimination by means of PET with 2-[F-18]fluoro-2-deoxy-D-glucose. , 1996, Radiology.

[21]  J. Hermans,et al.  REDUCED MORBIDITY FROM SKELETAL METASTASES IN BREAST CANCER PATIENTS DURING LONG-TERM BISPHOSPHONATE (APD) TREATMENT , 1987, The Lancet.

[22]  D. Rosenthal,et al.  Percutaneous biopsy of the cervical spine using CT guidance. , 1987, AJR. American journal of roentgenology.

[23]  D. Mitchell,et al.  Bull's-eyes and halos: useful MR discriminators of osseous metastases. , 1993, Radiology.

[24]  R. Khorasani,et al.  Fast spin-echo MR in the detection of vertebral metastases: comparison of three sequences. , 1994, AJNR. American journal of neuroradiology.

[25]  H. Pretorius,et al.  Bone scintigraphy and multimodality imaging in bone neoplasia: strategies for imaging in the new health care climate. , 1994, Seminars in nuclear medicine.

[26]  MR imaging of vertebral metastases: evaluation of fat saturation imaging. , 1993, European journal of radiology.

[27]  M. Simon,et al.  Evaluation, prognosis, and medical treatment considerations of metastatic bone tumors. , 1992, Orthopedics.

[28]  W. Martin,et al.  Scintigraphy with gallium-67 citrate in staging of soft-tissue sarcomas of the extremity. , 1987, The Journal of bone and joint surgery. American volume.

[29]  L. Gilula,et al.  Detection of bone-marrow metastases using quantitative computed tomography. , 1981, Radiology.

[30]  I. Carrió,et al.  Bone marrow regeneration after hormonal therapy in patients with bone metastases from prostate carcinoma. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.